e-therapeutics | 03-May-2024 | 18:00 | RNS |
Result of General Meeting | 29-Apr-2024 | 14:09 | RNS |
Proposed Fundraise of £28.9m and Cancellation | 10-Apr-2024 | 07:00 | RNS |
Total Voting Rights | 31-Jan-2024 | 16:30 | RNS |
Exercise of Options and Issue of Equity | 24-Jan-2024 | 10:04 | RNS |
Business Update | 16-Jan-2024 | 07:00 | RNS |
Director Dealing and Issue of Equity | 09-Jan-2024 | 16:04 | RNS |
Update on OTCQX Market Listing | 27-Dec-2023 | 07:00 | RNS |
Strategic RWE collaboration with Arcturis | 02-Nov-2023 | 07:00 | RNS |
Interim results for the six months to 31 July 2023 | 26-Oct-2023 | 07:38 | RNS |
Notice of Interim Results | 19-Oct-2023 | 09:54 | RNS |
Senior Management Update | 20-Sep-2023 | 07:00 | RNS |
Exercise of Options and Issue of Equity | 07-Sep-2023 | 11:47 | RNS |
Total Voting Rights | 31-Jul-2023 | 16:30 | RNS |
Result of Annual General Meeting | 18-Jul-2023 | 16:20 | RNS |
Currency | UK Pounds |
Share Price | 9.40p |
Change Today | -0.35p |
% Change | -3.59 % |
52 Week High | 23.10p |
52 Week Low | 8.13p |
Volume | 4,821,033 |
Shares Issued | 584.34m |
Market Cap | £54.93m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
12:33 | 1,834,972 @ 9.25p |
16:10 | 25,000 @ 9.50p |
15:45 | 54,184 @ 9.65p |
15:45 | 54,184 @ 9.60p |
15:45 | 54,184 @ 9.65p |
Chair | Trevor Mervyn Jones |
CEO | Ali Mortazavi |
You are here: research